E Pozzoli
Overview
Explore the profile of E Pozzoli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Berardinelli L, Pozzoli E, Beretta C, Consonni D, Carini M, Rossini G, et al.
Transplant Proc
. 2010 Jun;
42(4):1111-3.
PMID: 20534236
Long-term outcomes of renal transplantation using kidneys from donors >60 years old are generally considered to be poor. This retrospective study included 265 living donor (LD) transplants in adult recipients...
2.
Berardinelli L, Messa P, Pozzoli E, Beretta C, Montagnino G
Transplant Proc
. 2009 May;
41(4):1231-2.
PMID: 19460526
An increased development of malignancies has been related to modern potent antirejection drugs. The purpose of this retrospective study was to assess the incidence and risk factors for invasive malignancies...
3.
Raiteri M, Ferraresso M, Pozzoli E, Beretta C, Pasciucco A, Carini M, et al.
Transplant Proc
. 2005 Sep;
37(6):2472-3.
PMID: 16182713
The value of the resistive index (RI) obtained by echo color doppler evaluation of the transplanted kidney is still not well established. Many authors consider the RI to be nonspecific...
4.
Ferraresso M, Ghio L, Edefonti A, Garavaglia R, Pozzoli E, Berardinelli L
Transplant Proc
. 2001 Dec;
33(7-8):3590-1.
PMID: 11750525
No abstract available.
5.
Radaelli F, Faccini P, Goldaniga M, Guggiari E, Pozzoli E, MAIOLO A, et al.
Haematologica
. 2000 Oct;
85(10):1040-4.
PMID: 11025594
Background And Objectives: Splenectomy is the treatment of choice in the majority of patients affected by idiopathic thrombocytopenic purpura refractory to corticosteroid therapy, but it is not free from early...
6.
Annaloro C, Oriani A, Pozzoli E, Deliliers D, Bertolli V, Volpe A, et al.
Bone Marrow Transplant
. 2000 May;
25(8):837-41.
PMID: 10808204
Bone marrow histology after bone marrow transplantation has rarely been studied. Here, we reviewed the pre- and post-transplant bone marrow biopsies (BMB) of 40 acute myelogenous leukemia (AML) patients autografted...
7.
Annaloro C, Lambertenghi Deliliers G, Oriani A, Pozzoli E, Lambertenghi Deliliers D, Radaelli F, et al.
Haematologica
. 1999 Mar;
84(1):17-21.
PMID: 10091388
Background And Objective: The diagnostic and prognostic value of bone marrow biopsy (BMB) has been widely investigated in patients with chronic myeloproliferative disorders (CMPD). The present study is based on...
8.
Berardinelli L, Pasciucco A, Pozzoli E, Ferraresso M, Carini M, VEGETO A
Transplant Proc
. 1999 Mar;
31(1-2):294-5.
PMID: 10083113
No abstract available.
9.
Lambertenghi Deliliers G, Annaloro C, Pozzoli E, Oriani A, Della Volpe A, Soligo D, et al.
Leuk Res
. 1999 Mar;
23(3):291-7.
PMID: 10071084
Secondary myelodysplastic syndrome/acute myelogenous leukemia (MDS/AML) are today considered a primary complication of autologous hematopoietic stem cell transplantation. In our Center, 83 autografted patients underwent bone marrow (BM) biopsy and...
10.
Deliliers G, Tagliaferri E, Annaloro C, Della Volpe A, Soligo D, Pozzoli E, et al.
Prostaglandins Other Lipid Mediat
. 1998 Jul;
56(1):33-42.
PMID: 9674019
Forty-eight autografted patients were studied after treatment with granulocyte-colony stimulating factor (G-CSF) and were compared with a historical series of 24 patients autografted with bone marrow (BM) without G-CSF. When...